Unknown

Dataset Information

0

Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the Mycobacterium tuberculosis cellular envelope by glycosyl carbonate donors.


ABSTRACT: The global incidence of tuberculosis is increasing at an alarming rate, and Mycobacterium tuberculosis (Mtb) is the causative agent for tuberculosis, a disease with high mortality. Lipoarabinomannan (LAM) is one of the major components of the Mtb cellular envelope and is an attractive scaffold for developing anti-tubercular drugs, vaccines and diagnostics. Herein, a highly convergent strategy is developed to synthesize heneicosasaccharyl arabinomannan for the first time. The arabinomannan synthesized in this endeavour has several 1,2-trans or ?-Araf linkages and three 1,2-cis or ?-Araf linkages end capped with 1,2-trans or ?-Manp linkages. All the key glycosidations were performed with alkynyl carbonate glycosyl donors under [Au]/[Ag] catalysis conditions, which gave excellent yields and stereoselectivity even for the reactions between complex and branched oligosaccharides. The resultant allyl oligosaccharide was globally deprotected to obtain the heneicosasaccharyl arabinomannan as a propyl glycoside. In summary, heneicosasaccharyl mannose capped arabinomannan synthesis was achieved in 56 steps with 0.016% overall yield.

SUBMITTER: Islam M 

PROVIDER: S-EPMC5398307 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the <i>Mycobacterium tuberculosis</i> cellular envelope by glycosyl carbonate donors.

Islam Maidul M   Shinde Ganesh P GP   Hotha Srinivas S  

Chemical science 20161115 3


The global incidence of tuberculosis is increasing at an alarming rate, and <i>Mycobacterium tuberculosis</i> (Mtb) is the causative agent for tuberculosis, a disease with high mortality. Lipoarabinomannan (LAM) is one of the major components of the Mtb cellular envelope and is an attractive scaffold for developing anti-tubercular drugs, vaccines and diagnostics. Herein, a highly convergent strategy is developed to synthesize heneicosasaccharyl arabinomannan for the first time. The arabinomannan  ...[more]

Similar Datasets

| S-EPMC4707121 | biostudies-literature
| S-EPMC4015227 | biostudies-literature
| S-EPMC3518657 | biostudies-literature
| S-EPMC6299163 | biostudies-literature
| S-EPMC5725663 | biostudies-literature
| S-EPMC8006938 | biostudies-literature
2018-07-05 | PXD004164 | Pride
| S-EPMC2870982 | biostudies-literature
| S-EPMC3867987 | biostudies-literature
| S-EPMC5288502 | biostudies-literature